Matrix metalloproteinase-2 (MMP-2) is one of the most studied enzymes concerning their changes in peripheral blood concentration both in acute and chronic phases of post-stroke symptoms (Fatar et al., 2008; Kreisel et al., 2012, 2016). This evidence concerns the gene MMP2 and stroke disorder.